ELISA
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
CardiNor Nabs CE Mark for Cardiovascular Risk Test
The test measures secretoneurin, a novel biomarker that predicts mortality in patients with cardiovascular disease.
New Biomarker, Test From Wash U Team Aims to ID Patients at Higher Risk of Cardiovascular Disease
Premium
The diagnostic blood test for elevated serum fatty acid synthase detected patients at risk of chronic limb-threatening ischemia with 83 percent accuracy.
A new digital and microfluidic ELISA technique optimized for bedside diagnostics offers high sensitivity at low cost with fast turnaround times.
Zeus Scientific Gets FDA Emergency Use Authorization for SARS-CoV-2 Total Antibody Test
Late last year, the company received Emergency Use Authorization from the FDA for a test that detects IgG antibodies against SARS-CoV-2.
Mar 19, 2021
Mar 3, 2021
Feb 19, 2021
Feb 11, 2021
Eurofins Gets CE Mark for Coronavirus Antibody Test
Feb 10, 2021
VolitionRx Prices $20M Public Offering
Jan 4, 2021
Oct 28, 2020
Biodesix Prices $72M IPO
Oct 23, 2020